# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1646584 | F | Growth inhibition of human NCI-H2052 cells assessed as ATP level after 96 hrs by CellTiter-Glo assay | Homo sapiens | 1 | ALA1641579 | cell-based format | Scientific Literature | |
2. | ALA1692989 | F | Cytotoxicity against human NCI-H2052 cells after 48 hrs by sulforhodamine B assay | Homo sapiens | 3 | ALA1687923 | cell-based format | Scientific Literature | |
3. | ALA2039750 | F | Antiproliferative activity against human NCI-H2052 cells after 48 hrs by WST-8 assay | Homo sapiens | 1 | ALA2034861 | cell-based format | Scientific Literature | |
4. | ALA2363501 | F | SANGER: Inhibition of human NCI-H2052 cell growth in a cell viability assay. | Homo sapiens | 98 | ALA1201861 | cell-based format | Sanger Institute Genomics of Drug Sensitivity in Cancer | |
5. | ALA4807081 | F | Cytotoxicity against human H2052 cells assessed as reduction in cell viability and measured after 7 days by Celltiter-glo luminescent cell viability assay | Homo sapiens | 1 | ALA4806958 | cell-based format | Patent Bioactivity Data | |
6. | ALA5113310 | F | Antiproliferative activity against human NCI-H2052 cells assessed as inhibition of cell growth incubated for 72 hrs by CCK-8 assay | Homo sapiens | 1 | ALA5108089 | cell-based format | Scientific Literature | |
7. | ALA5262073 | F | Cytotoxicity against human NCI-H2052 cells measured after 8 days | Homo sapiens | 2 | ALA5260810 | cell-based format | Scientific Literature |